Synthesis of Doxycycline-[(CD3)-C-13]

Citation

Bordia, T., McGregor, M., Papke, R. L., McIntosh, M. J., Decker, M. W., & Quik, M. (2014, 15-19 November). The ?7 nicotinic receptor agonist ABT-107 protects against nigrostriatal damage in parkinsonian rats. Paper presented at Neuroscience 2014, Washington, DC.

Abstract

Doxycycline is a tetracycline antibiotic that is used to treat a wide variety of infections. A mass spectrometry (MS) analytical standard with M + 4 was prepared to support pharmacology and toxicology. Our approach was to first N-demethylate doxycycline and re-methylate using stable isotope labeled methyl-[13CD3] iodide to produce doxycycline-[13CD3]. An iron mediated Polonovsky reaction efficiently N-demethylated doxycycline. In this process, doxcycline was oxidized to the N-oxide using m-CPBA. The hydrochloride salt of the tertiary N-oxide was treated with Fe(0)/FeCl3 catalyst yielding the N-demethylated product. Isolated pure demethyldoxycycline was re-methylated using diisopropyl azodicarboxylate (DIAD), polymer-supported triphenylphosphine and methyl-[13CD3] iodide. We have synthesized labeled doxycycline with an isotopic purity of 99% using this methodology.

Keywords: MS internal standard; antibiotic; demethylation; doxycycline.


Read more from SRI

  • Banner and attendees at the IEEE Hard Tech Venture Summit

    Cultivating hard tech startups that scale

    IEEE’s Hard Tech Venture Summit convened innovators at SRI to refine strategies and build new networks.

  • Patient going into a MRI

    Bringing surgical tools inside the MRI

    Drawing on SRI’s unique innovation ecosystem, the startup Medical Devices Corner is seeking to improve cancer surgery by advancing MRI-safe teleoperation.

  • Christopher Mims and Susan Patrick

    PARC Forum: How to AI

    The Wall Street Journal tech columnist Christopher Mims and SRI Education’s Susan Patrick discuss how AI can strengthen human agency.